Sanofi (NASDAQ:SNY) went up to recover about 13.11% since recording its record low price of $38.97. The stock experienced 2.25% jump, arriving at $44.08 on 6/19/2019. During the day, the stock price traveled from $43.25 to $44.11. This company shares are 17.97% off its target price of $52 and the current market capitalization stands at $111.15B. The recent change has given its price a 4.49% lead over SMA 50 and -3.38% deficit over its 52-week high. The stock witnessed 6.4% gains, -2.93% declines and 1.15% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found SNY’s volatility during a week at 1.09% and during a month it has been found around 1.12%.
What Does Sanofi (SNY) Do?
The company describes itself in regulatory filings as, “Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.” [Text can be found here: https://www.marketwatch.com/investing/stock/SNY/profile under company description.]Sanofi (SNY) Top Holders
Institutional investors currently hold around $7.84 billion or 7.8% in SNY stock. Look at its top three institutional owners: Dodge & Cox owns $2.61 billion in Sanofi, which represents roughly 2.35% of the company’s market cap and approximately 33.33% of the institutional ownership. Similar statistics are true for the second largest owner, Barrow Hanley Mewhinney & Strauss Llc, which owns 22,577,280 shares of the stock are valued at $973.31 million. The third largest holder is Fisher Asset Management, Llc, which currently holds $711.34 million worth of this stock and that ownership represents nearly 0.64% of its market capitalization.
At the end of March reporting period, 188 institutional holders increased their position in Sanofi (NASDAQ:SNY) by some 9,128,022 shares, 251 decreased positions by 6,955,262 and 96 held positions by 165,708,066. That puts total institutional holdings at 181,791,350 shares, according to SEC filings. The stock grabbed 47 new institutional investments totaling 1,907,335 shares while 54 institutional investors sold out their entire positions totaling 1,751,723 shares.Sanofi (SNY) Analyst Guide
Several analysts have released their opinion on Sanofi (NASDAQ:SNY), with 3 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.5 average brokerage recommendation [T1].